Lori Rapuano

Lori J. Rapuano is Counsel in the Products Liability group, residing in our Philadelphia, Pennsylvania office. Lori’s practice is focused on the management of large-scale e-discovery projects in multi-jurisdictional pharmaceutical cases.

View the full bio for Lori Rapuano at the Faegre Drinker website.

Articles by Lori Rapuano:

Drafting 502(d) Orders to Provide Maximum Non-Waiver Protection


Counsel drafting an order under Federal Rule of Evidence 502(d) or an agreement under Rule 502(e) generally expect to supplant the uncertainty of the privilege waiver analysis under Rule 502(b) and assure near-absolute protection against inadvertent waiver. But two recent decisions frustrate such expectations and offer lessons on how to better assure strong anti-waiver protection. Absolute Activist Value Master Fund Ltd. v. Devine, 262 F. Supp. 3d 1312 (M.D. Fla. 2017); irth Solutions, LLC v. Windstream Communications, LLC, 2018 WL 575911 (S.D. Ohio 2018) (appeal pending).

Continue reading “Drafting 502(d) Orders to Provide Maximum Non-Waiver Protection”

Hallmarks of an Efficient Defendant Fact Sheet Process


Parties involved in coordinated proceedings featuring thousands of plaintiffs and a tight discovery schedule are expected to negotiate an efficient process for production of baseline data.  The Plaintiff Fact Sheet (PFS)/Defendant Fact Sheet (DFS) process provides an orderly procedure for discovery specific to plaintiffs and their prescribing/treating physicians.

Continue reading “Hallmarks of an Efficient Defendant Fact Sheet Process”